Impingement may either be predominantly anterior between the tibia and talus, or anterolateral between the fibula and talus. With the latter, pain is elicited by both dorsiflexion and eversion. 5 These syndromes are common sequelae of ankle trauma, either acute or repetitive, and can lead to profound limitations in activities of daily living. 6 Anterior or anterolateral ankle impingement can be managed conservatively with nonsteroidal anti-inflammatory medications, activity modification, bracing, and orthotics predominantly involving a small heel lift. Furthermore, physical therapy with an emphasis on proprioception and peroneal strengthening, particularly in the setting of concomitant instability may prove efficacious. 1 If conservative measures fail to provide appropriate symptomatic relief, operative intervention via an open or arthroscopic debridement may be necessary. [5] [6] [7] [8] [9] [10] [11] [12] Ultrasonography (US) has been shown to be advantageous for diagnosis and precise localization of ankle impingement. 1, 13, 14 The real-time visualization provided by US has also enabled image-guided corticosteroid injections. 1, 15 In this retrospective study, we used US to guide needle fenestration of pathological soft tissues combined with US-guided corticosteroid injection to treat anterior and/or anterolateral ankle impingement, similar to a technique previously reported for posterior ankle impingement. 15 We treated patients in whom soft tissue impingement was felt to be the predominant pathology, with or without associated osteophytes. We hypothesize that clinical improvement achieved by this technique may obviate subsequent operative management.
Methods
Institutional review board approval was obtained for this HIPAA (Health Insurance Portability and Accountability Act) compliant study. Because of the retrospective study design, the need for written informed consent was waived. However, verbal consent was obtained from all patients before administration of an institutional review board-approved telephone questionnaire.
Patient Selection
The office case records of a fellowshiptrained foot and ankle surgeon were queried for patients diagnosed with anterior or anterolateral ankle impingement. Inclusion criteria for this convenience sample were patients 18 years or older who underwent an US-guided needle fenestration and corticosteroid injection of the anterior ankle soft tissues between January 1, 2009 and May 31, 2014. Exclusion criteria were patients who were unavailable or unwilling to complete the telephone questionnaire.
Procedure Details
All diagnostic and interventional US procedures were performed by 1 of 3 musculoskeletal radiologists with extensive experience in musculoskeletal US. Initially, a diagnostic US study was performed using an iU22 unit (Philips Healthcare, Andover, MA) using a 12-5-MHz multifrequency linear or 15-7-MHz multifrequency compact linear transducer and a standard acoustic coupling gel (MediChoice, Owens and Minor, Mechanicsville, VA). Ankle impingement was diagnosed with the presence of hypoechoic scar tissue that wedged itself between the tibia and talus or between the fibula and talus on dynamic imaging in both active and passive ankle dorsiflexion ( Figures 1A and 2A) .
We used US to localize scar tissue implicated in anterior and/or anterolateral ankle impingement. The US probe was then covered with a sterile probe cover (Microtek Medical, Inc, Columbus, MS). The patient was prepped and draped in the usual sterile fashion using a chlorhexidine gluconate/ isopropyl alcohol scrub (ChloraPrep, Becton, Dickinson and Company, Franklin Lakes, NJ). The skin and subcutaneous tissues were numbed using approximately 5 mL of 1% lidocaine injected through a 25-gauge hypodermic needle (Becton, Dickinson and Company, Franklin Lakes, NJ). Using 10% povidone iodine solution (Betadine, Purdue Products, Stamford, CT) as an acoustic coupling agent (sterile gel if the patient had a known allergy to topical iodine), a hypodermic needle was advanced into the scar tissue under real-time US guidance, with the needle tip directed proximally to distally. The default size of the needle was 20-gauge, but an 18-gauge needle was used in cases where the scar tissue was calcified. The scar tissue was repeatedly fenestrated by the needle tip under continuous US visualization, and any calcifications were fragmented ( Figure  1B ). During this process if the patient reported sharp pain, additional 1% lidocaine was directly injected into the scar tissue as needed. Fenestration was continued until the needle glided effortlessly through the tissue, at which point the needle was redirected by US guidance to a different abnormal area-usually by fanning the needle out from the original puncture site but occasionally reestablishing a new starting point. After it appeared that all of the sonographically abnormal tissue had been treated, an admixture of 1 mL of triamcinolone acetonide (40 mg/mL) and 1 mL of 0.25% bupivacaine was injected. The needle was withdrawn, hemostasis maintained, and an adhesive bandage was placed over the needle puncture site. If the patient had both anterior and anterolateral impingement, the above procedure was performed at both locations at the same session.
Patients were instructed to avoid running or jumping activities for 1 week after the procedure, but there were otherwise no restrictions on activity. The foot was not placed in a boot or other specialized footwear. Patients were instructed to perform active and passive range-of-motion exercises and to follow up with the referring foot and ankle surgeon after a minimum of 2 weeks. If on subsequent visits to the foot and ankle surgeon it was determined that another procedure was necessary, the patient was referred back at varying intervals, minimum of 1 month.
Data Collection
One of the coauthors, a college undergraduate, attempted to contact all the patients by telephone in order to administer a questionnaire based on the Foot Function Index as presented in Budiman-Mak et al. 16 In addition to the questions on the Foot Function Index, patients were asked to rate their pain and discomfort on a scale of 0 to 10, 0 being no pain and 10 being the worst pain imaginable, before and after the procedure. They were also queried about their overall satisfaction with the procedure on a scale of 0 (completely unsatisfied) to 10 (very satisfied).
Data Analysis
Statistical analysis was performed using SAS software (SAS Inc, Cary, NC). Pain levels before and after the procedure were compared using a Student t test. To determine internal consistency of the patients' answers to the questionnaire, split half reliability was calculated using Cronbach's standardized coefficient alpha.
Results
A total of 109 patients were identified from the case record review, of which 92 had contact information available in the database. These 92 patients were called by telephone once every 2 weeks between August and January 2014 until they responded. Thirty-six patients never answered the phone, and 7 patients refused to participate. From those who could be contacted, 49/56 (87.5%) patients agreed to participate in the telephone survey and therefore constituted the study group. There were 26 women and 23 men. The average age was 42.7 years (range, 19-65 years). The treated impingement was categorized as anterior in 26/49 (53.1%), anterolateral in 14/49 (28.6%) and both in 9/49 (18.4%). If patients were treated on more than one date, they were asked to answer the questionnaire based on results of the first procedure. The average time between initial procedure and telephone follow-up was 27 months, range 2 to 63 months. The patients had a mean of 1.63 (range, 1-10) US-guided treatment sessions on the affected ankle. A total of 18/49(36.7%) patients underwent the treatment more than once. Repeat treatment was done if greater symptomatic relief was desired and/or symptoms recurred. Technique for repeat treatments was identical to the initial treatment.
None of the patients had remarkable bleeding, infection, or other serious complications. Of the patients, 10/49 (20.4%) eventually needed an operative procedure on the treated ankle because of insufficient clinical improvement: 5 patients had an arthroscopic procedure, 4 patients had an open procedure, and 1 patient needed more than 1 procedure. The average time between initial treatment and surgery was 9.3 months, range 1 to 13 months.
Questionnaire Responses
Cronbach's standardized coefficient alpha was 0.93, indicating high level of internal consistency among the answers. Mean pain level before the procedure was 6.76 ± 1.84, and mean pain level after the procedure was 2.73 ± 2.21. On average, reported pain scale levels declined by 4.02 ± 2 units after the procedure. The Student t test showed that the difference between pre-and postprocedure pain scale levels was significant (P < .0001). Patient's overall satisfaction with the procedure was 7.9 ± 2.44.
The first 5 questions on the Foot Function Index assessed foot pain levels in different situations over the past week on a scale of 0 (no pain) to 10 (worst pain imaginable). The situations were taking the first step in the morning (3 ± 2.92), walking (2.76 ± 2.59), standing (2.8 ± 2.76), at the end of the day (3.17 ± 2.53), and pain at its worst (5.82 ± 3.27).
The next 9 questions on the Foot Function Index assessed the difficulty in performing tasks of daily life related to foot pain on a scale of 0 (no difficulty) to 10 (so difficult, activity could not be done. The 9 tasks were walking in the house (1.28 ± 2), walking outside (2.26 ± 2.44), walking 4 blocks (3.3 ± 3.15), climbing stairs (2.63 ± 2.84), descending stairs (2.78 ± 2.74), standing tip toe (4.04 ± 3.98), getting up from a chair (1.2 ± 1.72), climbing curbs (2.09 ± 2.45), and running or fast walking (5.54 ± 3.51).
The final 3 questions on the Foot Function Index assessed how often certain accommodations had to be made because of pain over the past week on a scale of 0 (none of the time) to 10 (all of the time). The accommodations included using an assistive device (cane, walker, crutches, etc) indoors (0.33 ± 1.46), using an assistive device outdoors (0.67 ± 2.07) or limiting physical activities (3.59 ± 2.86).
Discussion
Arthroscopic surgery for anterior and/ or anterolateral ankle impingement is advocated in the setting of failed conservative treatment. Compared with open surgery, arthroscopic surgery for anterior and/or anterolateral ankle impingement provides the advantages of quicker recovery time, decreased scarring, and repeatability. 6 Numerous studies exist reporting outcomes after arthroscopic treatment of ankle impingement. A study published in 1997 by Branca et al 6 treated 133 patients for anterior ankle impingement with a 4-to 6-month trial of conservative management, including rest, physical therapy, nonsteroidal anti-inflammatory medications, and shoe modifications. Of these patients, 58/133 (43.6%) failed to improve and went on to have arthroscopic surgery. Follow-up at mean 21.5 months showed 37/58 (64%) good, 13/58 (22%) fair, and 8/58 (14%) poor results. 6 Other authors have subsequently reported similar results of arthroscopic surgery for anterior and anterolateral impingement or anterolateral ankle impingement alone. 5, 8, 11 In contrast to arthroscopic ankle surgery, high-resolution real-time imaging afforded by US permits ankle impingement to be treated even less invasively in a percutaneous manner. 15 Ultimately, many of the aforementioned benefits of arthroscopy compared with open surgery would also apply to percutaneous treatment compared to arthroscopy, but only if success rates were comparable. The current study shows that our US-guided percutaneous technique was indeed successful in reducing pain and improving function for anterior and anterolateral ankle impingement. This treatment is meant to be definitive management as an alternative to operative treatment. The goal of this procedure and the hypothesis posed in this study is that clinical improvement achieved by this technique may obviate subsequent operative management. The criteria for operative management was failure of US-guided percutaneous needle fenestration and corticosteroid injection generally after a minimum of 6 months from the date of the procedure, in addition to failure of other conservative care, including nonsteroidal antiinflammatory medications, activity modification, bracing, and orthotics predominantly involving a small heel lift.
Only about 1 out of 5 patients went on to need surgery. Considering these patients to be the treatment failures secondary to symptom recurrence the percutaneous procedure was still successful 39/49 (79.6%) of the time. Robinson and Bollen 15 reported success with a similar fenestration and injection technique to treat posterior ankle impingement in a small series of 10 professional soccer players, but numbers in that study were too small to allow direct comparison with our results. We are not aware of any other studies that used a similar technique.
Potential rationales for performing needle fenestration before the corticosteroid injection include mechanical softening of the pathologic scar tissues along with the development of tiny fissures within the soft tissue for the corticosteroid solution to diffuse. In addition to its anti-inflammatory effects, corticosteroids, in particular triamcinolone, have been long known to inhibit fibroblast growth and promote collagen degradation. 17 This latter mechanism of action may be the most important in our patients, similar to the benefit observed in percutaneous intralesional corticosteroid injections to treat keloids and hypertrophic scars. 18 It makes intuitive sense that physically shrinking the hypertrophied tissue should reduce the symptoms of ankle impingement. Of course, if coexistent bony impingement is present, there should be a higher incidence of recurrent symptoms, but we did not study this specific question.
The study has several limitations. This was a retrospective study that had no control group comparing either to placebo or to surgery. There is a recall bias in that the patients were asked to recall the results of a procedure done sometime before the phone interview. In addition, if a patient had more than one procedure, recalling the outcome of the first procedure could have been difficult. Response bias is also possible in a survey of this type; those agreeing to answer the survey may have been more likely to report a successful outcome. Finally, it cannot be determined how much of the recovery of the patients was due to fenestration of the scar tissue versus the corticosteroid injection.
Conclusion
US-guided percutaneous needle fenestration and corticosteroid injection appears to be an effective nonoperative alternative for the treatment of anterior and/or anterolateral ankle impingement. We feel that the procedure should be attempted before surgery is contemplated, since in our series it prevented operative intervention in approximately 80% of the surveyed patients.
